NS

Neeraj Singh Chauhan

Active Director Director DIN 11391612
DIN 11391612 First appointment Nov 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Neeraj Singh Chauhan

Data last updated:

Neeraj Singh Chauhan is a Director at Aroxima Lifesciences Private Limited (since 2025). The company operates in Pharma.

DIN 11391612
Primary Designation Director
Industry Pharma
First Appointment 24 Nov 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aroxima Lifesciences Private Limited U46497GJ2025PTC163572
Director24 Nov 2025Active

Board colleagues of Neeraj Singh Chauhan

Directorship timeline

Open interactive timeline →
Aroxima Lifesciences Private Limited
Premium access

Shareholding and investment profile for Neeraj Singh Chauhan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neeraj Singh Chauhan

Neeraj Singh Chauhan currently holds 1 directorship: Aroxima Lifesciences Private Limited (Director, since 24 Nov 2025).

Neeraj Singh Chauhan was first appointed on 24 Nov 2025 as Director at Aroxima Lifesciences Private Limited.

The current boards of Neeraj Singh Chauhan's companies include Arun Vasudev Mishra (Aroxima Lifesciences Private Limited), Ashok Kumar (Aroxima Lifesciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available